Getinge AB is a global medical technology company headquartered in Gothenburg, Sweden, that develops and manufactures products for hospitals and life science institutions. The company's business model is built on providing capital equipment, consumables, and service contracts, which generate a steady stream of recurring revenue. Getinge operates through three primary business segments. Acute Care Therapies (approximately 52% of 2023 net sales) offers solutions for life support in acute health conditions, including ventilators, extracorporeal life support (ECLS) systems, and intra-aortic balloon pumps. Surgical Workflows (approximately 34% of sales) provides products for operating rooms and sterile reprocessing, such as surgical tables, surgical lights, and high-capacity sterilizers and disinfectors. Life Science (approximately 14% of sales) supplies equipment and consultation services for contamination prevention in biopharmaceutical production and biomedical research. Geographically, Getinge has a global footprint, with the Americas (particularly the United States) representing its largest market, followed by EMEA and the APAC region. The company maintains a strong competitive position through continuous R&D investments, strategic acquisitions (such as Healthmark and Paragonix Technologies), and a focus on improving clinical outcomes and operational efficiency for healthcare providers.
